In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor ...
Feb 5, 2014
0
0
The effectiveness of one of the most widely used anti-coagulant drugs can be improved if genotype testing is carried out before the dose is decided, according to the findings of a new study from the University of Liverpool, ...
Nov 20, 2013
0
0
According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ...
Oct 31, 2013
0
0
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...
Oct 30, 2013
0
0
(HealthDay)—There are multiple independent risk factors for the development of deep venous thrombosis (DVT) and/or pulmonary embolism (PE) after spine surgery, according to a study published in the Oct. 1 issue of Spine.
Oct 18, 2013
0
0
Cutting-edge research from the University of Reading has provided a crucial breakthrough in understanding how blood clots form. The results of the study, funded by the British Heart Foundation (BHF), could potentially lead ...
Oct 8, 2013
0
0
British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros).
Sep 30, 2013
0
0
In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin ...
Sep 1, 2013
0
0
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing ...
Aug 30, 2013
0
0
In Austria, around 15,000 people a year develop a venous thrombosis, the occlusion of a vein that can result in a pulmonary embolism. A clot breaks free from a vein and travels via the bloodstream to the lungs, where it blocks ...
Aug 14, 2013
0
0
